Bridgeway Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,750
| Closed | -$52.5K | – | 1427 |
|
|
2023
Q1 | $52.5K | Hold |
3,750
| – | – | ﹤0.01% | 1306 |
|
|
2022
Q4 | $38.2K | Sell |
3,750
-440
| -11% | -$4.48K | ﹤0.01% | 1317 |
|
|
2022
Q3 | $54K | Buy |
+4,190
| New | +$54K | ﹤0.01% | 1344 |
|
|
2022
Q2 | – | Sell |
-2,690
| Closed | -$101K | – | 1370 |
|
|
2022
Q1 | $101K | Buy |
+2,690
| New | +$101K | ﹤0.01% | 1259 |
|
|
2020
Q2 | – | Sell |
-1,750
| Closed | -$398K | – | 1368 |
|
|
2020
Q1 | $398K | Sell |
1,750
-4,250
| -71% | -$967K | 0.01% | 841 |
|
|
2019
Q4 | $1.48M | Sell |
6,000
-500
| -8% | -$123K | 0.02% | 638 |
|
|
2019
Q3 | $371K | Sell |
6,500
-890
| -12% | -$50.8K | 0.01% | 1045 |
|
|
2019
Q2 | $349K | Hold |
7,390
| – | – | ﹤0.01% | 1066 |
|
|
2019
Q1 | $398K | Buy |
+7,390
| New | +$398K | 0.01% | 1087 |
|
|
2018
Q4 | – | Sell |
-4,500
| Closed | -$264K | – | 1428 |
|
|
2018
Q3 | $264K | Buy |
4,500
+2,000
| +80% | +$117K | ﹤0.01% | 1276 |
|
|
2018
Q2 | $133K | Hold |
2,500
| – | – | ﹤0.01% | 1345 |
|
|
2018
Q1 | $704K | Hold |
2,500
| – | – | 0.01% | 971 |
|
|
2017
Q4 | $588K | Hold |
2,500
| – | – | 0.01% | 1040 |
|
|
2017
Q3 | $710K | Hold |
2,500
| – | – | 0.01% | 974 |
|
|
2017
Q2 | $704K | Hold |
2,500
| – | – | 0.01% | 965 |
|
|
2017
Q1 | $835K | Hold |
2,500
| – | – | 0.01% | 879 |
|
|
2016
Q4 | $826K | Sell |
2,500
-600
| -19% | -$198K | 0.01% | 891 |
|
|
2016
Q3 | $828K | Hold |
3,100
| – | – | 0.01% | 880 |
|
|
2016
Q2 | $410K | Buy |
3,100
+2,500
| +417% | +$331K | 0.01% | 1130 |
|
|
2016
Q1 | $106K | Sell |
600
-150
| -20% | -$26.5K | ﹤0.01% | 1371 |
|
|
2015
Q4 | $187K | Hold |
750
| – | – | ﹤0.01% | 1315 |
|
|
2015
Q3 | $211K | Hold |
750
| – | – | ﹤0.01% | 1295 |
|
|
2015
Q2 | $104K | Buy |
+750
| New | +$104K | ﹤0.01% | 1428 |
|